ArticleScientific reports2024

Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease.

M Soulié et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.